In human CRC cells, TUSC3 inhibited EGFR signaling, an exemplary target protein of OST-mediated N-glycosylation in the ER, thus providing one potential mechanism by which loss of TUSC3 contributes to progression of CRC. The gene discussed is EGFR; the disease is colorectal carcinoma.